PATENT CLAIM ANALYSIS

Application Number: 16241215
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["514", "301000"]

Abstract:
Described herein are novel compounds and methods for the treatment and/or prevention of cerebral amyloidoses such as Alzheimer's disease (AD) and/or cerebral amyloid angiopathy (CAA).

Claim (Index 1):
A compound having a structure represented by formula I or IA: wherein:\n R 1  is chosen from H, C 1 -C 8  alkyl and benzyl; \n R 2 , R 4  are independently chosen from H, C 1 -C 8  alkyl, aryl, (CH 2 ) n  aryl, (CH 2 ) n  heteroaryl; \n n=0-8; \n X 1 , X 2  are independently chosen from CO, SO, SO 2 , \u2014CONH\u2014, SO 2 NH\u2014, SONH\u2014; and \n A 1 , A 2 , B 1 , B 2 , C 1 , C 2  are independently chosen from H, OR 4 , F, \n with the proviso that the compound is not 2-acetamido-1,2-dideoxynojirimycin or 2-acetamido-1,2-dideoxygalactonojirimycin, or a pharmaceutically acceptable salt or solvate thereof.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 99.0
- Lexical Diversity: 1.14815
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16004723', '15377437', '13390856', '14009654', '15509984']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7902674092938574
- 35 USC 102 Novelty (BERT): 0.5255386577037734
- Combined Prediction Score: 0.763794534134849
- Mean Citation Score: 291.08354799999995
- Max Citation Score: 346.7746
- Similarity Product: 317.3987028780461

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test